Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Intrexon (XON) +4.8% AH after David Einhorn's Greenlight

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dav1234 Member Profile
 
Followed By 119
Posts 93,348
Boards Moderated 4
Alias Born 10/29/07
160x600 placeholder
Putin Circumspect on Re-Election, but Critical of Western Sanctions
Russian President Vladimir Putin said he would not retain his post forever, but doesn't rule out running in 2018, and said the Western sanctions against Moscow violate human rights and are aimed at sowing discord in Russian society.
China Mobile's Need for Speed -- Barron's Asia
Zoetis Unveils $500 Million Stock Buyback Plan -- Update
Intel Projects More Growth in 2015 -- Update
Appeals Court Grants TV Programmers Stay in FCC Dispute -- Update
Technip Bids for CGG -- 2nd Update
Wireless Carriers Bid Up US Airwaves To Record
Faith-Based Shareholders Prepare Day of Reckoning for Bank of America
Chinese Premier Plays Down Qualcomm's Woes
Activision Blizzard to Get $275 Million in Settlement
dav1234   Thursday, 11/14/13 06:09:02 PM
Re: None
Post # of 184130 
Intrexon (XON) +4.8% AH after David Einhorn's Greenlight Capital reveals it opened a ~2.1M-share position in the biotech company that went public in August

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist